Page
%P
-
Article
Autologous stem-cell collection following VTD or VRD induction therapy in multiple myeloma: a single-center experience
Triplet-drug regimen bortezomib–thalidomide–dexamethasone (VTD) and bortezomib–lenalidomide–dexamethasone (VRD) are considered as standard of care induction prior autologous stem-cell transplantation (ASCT) in...